Combination therapy for treating cancer with an intravenous administration of a recombinant MVA and an antibody

• 收藏
• 分享

专利权人:

Bavarian Nordic A/S

发明人:

HOCHREIN, Hubertus,LAUTERBACH, Henning,MEDINA ECHEVERZ, Jose,HABJAN, Matthias

申请号：

AU2018320417

公开号：

AU2018320417A1

申请日:

2018.08.23

申请国别(地区):

AU

年份:

2020

代理人:

摘要：

The disclosure relates to a pharmaceutical combination consisting of a MVA-TAA (Modified Vaccinia Ankara virus with a tumor-associated antigen) with a second antibody, methods for reducing tumor volume and/or increasing the survival of a cancer patient. The combination further comprises an intravenous administration of a recombinant MVA encoding a tumor-associated antigen and an administration of an antibody to a cancer patient.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/